Atomistry » Magnesium » PDB 4nm0-4nxn » 4nmm
Atomistry »
  Magnesium »
    PDB 4nm0-4nxn »
      4nmm »

Magnesium in PDB 4nmm: Crystal Structure of A G12C Oncogenic Variant of Human Kras Bound to A Novel Gdp Competitive Covalent Inhibitor

Enzymatic activity of Crystal Structure of A G12C Oncogenic Variant of Human Kras Bound to A Novel Gdp Competitive Covalent Inhibitor

All present enzymatic activity of Crystal Structure of A G12C Oncogenic Variant of Human Kras Bound to A Novel Gdp Competitive Covalent Inhibitor:
3.6.5.2;

Protein crystallography data

The structure of Crystal Structure of A G12C Oncogenic Variant of Human Kras Bound to A Novel Gdp Competitive Covalent Inhibitor, PDB code: 4nmm was solved by J.C.Hunter, D.Gurbani, S.M.Lim, K.D.Westover, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 45.58 / 1.89
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 39.088, 42.022, 91.159, 90.00, 90.00, 90.00
R / Rfree (%) 18.4 / 23.7

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Crystal Structure of A G12C Oncogenic Variant of Human Kras Bound to A Novel Gdp Competitive Covalent Inhibitor (pdb code 4nmm). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Crystal Structure of A G12C Oncogenic Variant of Human Kras Bound to A Novel Gdp Competitive Covalent Inhibitor, PDB code: 4nmm:

Magnesium binding site 1 out of 1 in 4nmm

Go back to Magnesium Binding Sites List in 4nmm
Magnesium binding site 1 out of 1 in the Crystal Structure of A G12C Oncogenic Variant of Human Kras Bound to A Novel Gdp Competitive Covalent Inhibitor


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Crystal Structure of A G12C Oncogenic Variant of Human Kras Bound to A Novel Gdp Competitive Covalent Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg201

b:37.8
occ:1.00
 O8 A:Y9Z202 1.9 22.8 1.0
OG A:SER17 2.2 26.7 1.0
O A:HOH424 2.3 32.9 1.0
O A:HOH425 2.3 27.3 1.0
O A:HOH306 2.4 28.3 1.0
C11 A:Y9Z202 2.5 26.9 0.5
C10 A:Y9Z202 2.5 27.8 0.5
P1 A:Y9Z202 3.0 23.4 1.0
CB A:SER17 3.2 24.7 1.0
O5 A:Y9Z202 3.2 29.0 1.0
CD2 A:TYR32 3.7 51.4 1.0
O10 A:Y9Z202 3.7 26.3 1.0
N5 A:Y9Z202 3.9 28.5 0.5
O4 A:Y9Z202 4.0 29.6 1.0
N A:SER17 4.0 24.5 1.0
CA A:SER17 4.1 23.8 1.0
OD2 A:ASP57 4.2 36.2 1.0
O7 A:Y9Z202 4.2 20.8 1.0
CE2 A:TYR32 4.2 54.2 1.0
P A:Y9Z202 4.2 26.9 1.0
O9 A:Y9Z202 4.3 28.2 1.0
O A:ASP33 4.3 38.3 1.0
OD1 A:ASP57 4.3 42.8 1.0
CA A:PRO34 4.6 41.9 1.0
O A:ILE36 4.6 29.1 1.0
CG A:ASP57 4.7 33.9 1.0
O A:PRO34 4.8 39.7 1.0
CG A:TYR32 4.8 55.7 1.0
O A:TYR32 4.8 42.6 1.0
O A:HOH336 4.8 29.5 1.0
O A:THR58 4.9 22.2 1.0
C A:PRO34 5.0 42.5 1.0
C12 A:Y9Z202 5.0 27.1 0.5

Reference:

J.C.Hunter, D.Gurbani, S.B.Ficarro, M.A.Carrasco, S.M.Lim, H.G.Choi, T.Xie, J.A.Marto, Z.Chen, N.S.Gray, K.D.Westover. In Situ Selectivity Profiling and Crystal Structure of Sml-8-73-1, An Active Site Inhibitor of Oncogenic K-Ras G12C. Proc.Natl.Acad.Sci.Usa V. 111 8895 2014.
ISSN: ISSN 0027-8424
PubMed: 24889603
DOI: 10.1073/PNAS.1404639111
Page generated: Mon Aug 19 23:43:31 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy